231 related articles for article (PubMed ID: 15242240)
1. Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Liu ML; James RW; Ylitalo K; Taskinen MR
Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):81-7. PubMed ID: 15242240
[TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
3. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
4. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
[TBL] [Abstract][Full Text] [Related]
5. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
van Himbergen TM; van Tits LJ; Ter Avest E; Roest M; Voorbij HA; de Graaf J; Stalenhoef AF
Atherosclerosis; 2008 Jul; 199(1):87-94. PubMed ID: 18096166
[TBL] [Abstract][Full Text] [Related]
8. Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.
Kar S; Patel MA; Tripathy RK; Bajaj P; Pande AH
Biochim Biophys Acta; 2013 Dec; 1831(12):1714-20. PubMed ID: 23973798
[TBL] [Abstract][Full Text] [Related]
9. Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging.
Cherki M; Berrougui H; Isabelle M; Cloutier M; Koumbadinga GA; Khalil A
Exp Gerontol; 2007 Aug; 42(8):815-24. PubMed ID: 17532162
[TBL] [Abstract][Full Text] [Related]
10. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
11. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
12. Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor.
Moreno-Godínez ME; Galarce-Sosa C; Cahua-Pablo JÁ; Rojas-García AE; Huerta-Beristain G; Alarcón-Romero LDC; Cruz M; Valladares-Salgado A; Antonio-Véjar V; Ramírez-Vargas MA; Flores-Alfaro E
Arch Med Res; 2018 Oct; 49(7):486-496. PubMed ID: 30853125
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 status in the Thai population.
Phuntuwate W; Suthisisang C; Koanantakul B; Mackness MI; Mackness B
J Hum Genet; 2005; 50(6):293-300. PubMed ID: 15924216
[TBL] [Abstract][Full Text] [Related]
14. PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.
Jaouad L; Milochevitch C; Khalil A
Free Radic Res; 2003 Jan; 37(1):77-83. PubMed ID: 12653220
[TBL] [Abstract][Full Text] [Related]
15. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
16. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
[TBL] [Abstract][Full Text] [Related]
17. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
[TBL] [Abstract][Full Text] [Related]
18. The paraoxonase 1, 2 and 3 in humans.
Rajkovic MG; Rumora L; Barisic K
Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
[TBL] [Abstract][Full Text] [Related]
19. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
Gaidukov L; Tawfik DS
Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
[TBL] [Abstract][Full Text] [Related]
20. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
